For example, studies have shown that using a second mitochondria-derived activator of caspase (SMAC) mimetic can induce necroptosis and overcome drug resistance in caspase-8-deficient CRC mouse models (He et al., 2017). Here, CASP8 is linked to colorectal carcinoma.